LifeArc, Metrion Biosciences extend partnership agreement

15:23 EDT 1 Aug 2017 | CentreWatch

Metrion Biosciences, a specialist ion channel CRO and drug discovery company, and LifeArc, the U.K. medical research charity previously known as MRC Technology, announced an extension of their existing partnership, to support LifeArc’s neuroscience drug discovery program. Under the terms of the agreement Metrion will provide validated ion channel and electrophysiology-based assays and safety profiling […]

The post LifeArc, Metrion Biosciences extend partnership agreement appeared first on CenterWatch News Online.

Original Article: LifeArc, Metrion Biosciences extend partnership agreement


More From BioPortfolio on "LifeArc, Metrion Biosciences extend partnership agreement"

Quick Search

Relevant Topics

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...